| Teva Pharma AG - Pomalidomid-Teva 1 mg, Hartkapseln | | 69576 | | 01 | | Pomalidomid-Teva 1 mg | | Hartkapseln | | L04AX06 | | Pomalidomide | | 04.11.2024 | | |
| | Composition | | pomalidomidum 1 mg, lactosum monohydricum 50 mg, crospovidonum, povidonum K 30, natrii laurilsulfas, natrii stearylis fumaras, Kapselhülle: E 133, E 171, gelatina, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.135 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Pomalidomidum | 1 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pomalidomidum | 1 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Crospovidonum | | | | E 133 | | Kapselhülle | | E 171 | | color. | | E 172 | | color. | | Gelatina | | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactose Monohydrate | 50 mg | | | Natrii Laurilsulfas | | | | Natrii Stearylis Fumaras | | | | Povidonum K | 30 | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 14 | DDP | DDP | A | | Non | | 002 | 21 | 3125.67 | 3415.75 | A | LS | Non |
|
|
